TrialEuropean journal of nuclear medicine and molecular imaging2025

Novel framework for response evaluation criteria in grade 1/2 neuroendocrine tumors (RECIN) following [

Swayamjeet Satapathy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.